Despite decades of experience, advanced health systems, and deep medical knowledge, the WHO European region is still at risk from the global epidemic of tuberculosis. There are at least three pressing ...
In the 1980s, after decades of steadily declining rates of tuberculosis, ambitious plans were made to eliminate the disease in the United States. Despite these plans, the control of tuberculosis was ...
The Starting Antiretroviral Therapy at Three Points in Tuberculosis (SAPIT) trial, reported in 2010 by Abdool Karim et al., 9 was an open-label, randomized, controlled trial involving 642 HIV-infected ...